NASDAQ · Biotechnology

Geron Corporation (GERN)

$0.87 -4.63%
44 In band Daily RSI (14) · 18 Nov 2026

Moving averages

SMA 200$1.41-38.25%

Company profile

Geron Corporation, an advanced stage clinical biopharmaceutical company, focuses on the development and commercialization of therapies for myeloid hematologic neoplasms. The company is headquartered in Foster City, California.

SectorHealthcare
IndustryBiotechnology
Market cap$640.37M
P/E ratioNone
EPS$-0.08
Beta0.611
Dividend yield0.00%
52-week high$2.01
52-week low$0.84

Similar stocks in Biotechnology

30 days of PRO Unlimited free, no card

RSI alerts for GERN

An email when GERN closes below RSI 30 or above 70. Nothing else.

Data last updated 13 November 2026 at 7:15 AM EST